China Lilang Reports No Share Capital Changes in July; Public Float Remains Adequate

Bulletin Express
Aug 03

China Lilang Limited (China Lilang) submitted its Monthly Return for Equity Issuer to the Hong Kong Stock Exchange for the period ended 31 July 2026. Key highlights are as follows:

• Authorised share capital unchanged: The company’s authorised share count stayed at 100.00 billion ordinary shares at a par value of HKD 0.10, representing total authorised capital of HKD 10.00 billion.

• Issued share base stable: Issued ordinary shares (excluding treasury shares) remained at 1.20 billion, with no issuance, cancellation or repurchase activity during the month. No treasury shares were held.

• Public float compliance: Management confirmed that the public float comfortably met the Main Board’s minimum 25 % requirement as of 31 July 2026.

• Share option position: – Outstanding options: 10.74 million options with an exercise price of HKD 4.31 each. – Activity: No options were exercised, cancelled or lapsed; consequently, no new shares were issued and the outstanding option pool was unchanged.

• No warrants, convertibles, or other share-related instruments were issued, exercised or cancelled in July.

The monthly filing, signed by Company Secretary Shum Chi Chung on 3 August 2026, confirms that all regulatory obligations under Hong Kong Listing Rules have been met and that all securities of the same class remain identical in rights and ranking.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10